Revelation Biosciences raises ~$3.8M via warrant exercises; issues new warrants

REVELATION BIOSCIENCES, INC.

Class D warrant holders exercise 2,548,060 shares at reduced price of $1.50/share, gross proceeds ~$3.8M.
New Inducement Warrants issued to purchase up to 5,096,120 shares at $1.00/share, exercisable for 5 years.
Net proceeds to fund GEM-AKI, GEM-CKD, GEM-PSI clinical trials and working capital.
Roth Capital Partners paid ~$267,546 advisory fee; exercise prices of certain Class C/D warrants adjusted to $1.00.

item 1.01 item 3.02 item 3.03 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.